Apelin-13 facilitates lordosis behavior following infusions to the ventromedial hypothalamus or preoptic area in ovariectomized, estrogen-primed rats

Neurosci Lett. 2022 Mar 16:773:136518. doi: 10.1016/j.neulet.2022.136518. Epub 2022 Feb 9.

Abstract

In normal hormonal conditions, increased neuronal activity in the ventromedial hypothalamus (VMH) induces lordosis whereas activation of the preoptic area (POA) exerts an opposite effect. In the present work, we explored the effect of bilateral infusion of different doses of the apelin-13 (0.37, 0.75, 1.5, and 15 μg) in both brain areas on the expression of lordosis behavior. Lordosis quotient and lordosis reflex score were performed at 30, 120, and 240 min. Weak lordosis was observed following the 0.37 μg dose of apelin-13 at 30 min in the VMH of EB-primed rats; however, the rest of the doses induced significant lordosis relative to the control group. At 120 min, all doses induced lordosis behavior, while at 240 min, the highest dose of 15 μg did not induce significant differences. Interestingly, only the 0.75 μg infusion of apelin in the POA induced significant lordosis at 120 and 240 min. These results indicate that apelin-13 acts preferably in HVM and slightly in POA to initiate lordosis behavior in estrogen-primed rats.

Keywords: Apelin-13; Lordosis; Preoptic area; Ventromedial hypothalamus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Estradiol / pharmacology
  • Estrogens / pharmacology
  • Hypothalamus / drug effects
  • Hypothalamus / pathology
  • Intercellular Signaling Peptides and Proteins* / pharmacology
  • Lordosis* / chemically induced
  • Preoptic Area* / drug effects
  • Preoptic Area* / pathology
  • Progesterone / pharmacology
  • Rats
  • Sexual Behavior, Animal / drug effects
  • Ventromedial Hypothalamic Nucleus / drug effects
  • Ventromedial Hypothalamic Nucleus / pathology

Substances

  • Estrogens
  • Intercellular Signaling Peptides and Proteins
  • apelin-13 peptide
  • Progesterone
  • Estradiol